
CJC-1295 Peptide Therapy
Benefits, Side Effects, Cost & Protocols
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue developed by ConjuChem Biotechnologies. It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Who Is CJC-1295 Best For?
How CJC-1295 Works
Stimulates the pituitary gland to release growth hormone by mimicking natural GHRH signaling. The DAC version provides sustained release while the non-DAC version allows more natural pulsatile patterns.
CJC-1295 FAQ
What is CJC-1295?
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog available in two forms: with DAC (Drug Affinity Complex) for extended half-life, and without DAC (MOD GRF 1-29) for more pulsatile release. It's one of the most established peptides for growth hormone research.
How does CJC-1295 work?
Stimulates the pituitary gland to release growth hormone by mimicking natural GHRH signaling. The DAC version provides sustained release while the non-DAC version allows more natural pulsatile patterns.
Is CJC-1295 legal to buy?
CJC-1295 requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.
Where can I buy CJC-1295?
CJC-1295 is available through compounding pharmacies with a valid prescription. Our directory lists verified pharmacies that compound this peptide.
What category does CJC-1295 belong to?
CJC-1295 is primarily classified as a growth hormone secretion peptide. Peptides that stimulate or support growth hormone release, including GHRH analogs, GHRPs, and direct GH compounds for muscle, recovery, and anti-aging research.
What are the research benefits of CJC-1295?
CJC-1295 has been studied for: Growth hormone secretion, Muscle support, Recovery, Anti-aging research, Body composition. Classic GHRH analog; available in compounding pharmacies.
Key Studies
30 total on PubMed17 human trialsActivation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects
Sackmann-Sala L, Ding J, Frohman LA et al
Growth Horm IGF Res · Growth Horm IGF ResPhase 1
CJC-1295 altered serum protein profiles including apolipoprotein A1 and transthyretin as potential GH/IGF-1 biomarkers.
CJC-1295 altered serum protein profiles including apolipoprotein A1 and transthyretin as potential GH/IGF-1 biomarkers
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Teichman SL, Neale A, Lawrence B et al
J Clin Endocrinol MetabPhase 1
CJC-1295 produced sustained dose-dependent increases in GH and IGF-I levels with good safety profile
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
J Clin Endocrinol MetabPhase 1
CJC-1295 increased GH and IGF-I levels while preserving normal GH pulsatile secretion patterns
The study of doping market: How to produce intelligence from Internet forums
Pineau T, Schopfer A, Grossrieder L et al
Forensic Sci Int · Forensic Sci Int
CJC-1295 Compound Data
CJC-1295 News
The peptide problem: Hype is outrunning the evidence - The Conversation
The Conversation · 12 days ago
Umbrella Lab Announces Documentation And Traceability Update For CJC-1295 (NO DAC)/Ipamorelin Peptide Blend - Yahoo Finance
Yahoo Finance · 5 days ago
CJC 1295 Ipamorelin Unveiled 2026: Examining the Science - GlobeNewswire
GlobeNewswire · 4 months ago
CJC-1295 and Penis Growth: What the Evidence Actually Shows - Portal CNJ
Portal CNJ · 9 days ago
RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work. - ProPublica
ProPublica · 1 month ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore CJC-1295 with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in CJC-1295.
Take the Quiz →